Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.
about
Neurobiological Insights from mGlu Receptor Allosteric Modulation.Potential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsTargeting metabotropic glutamate receptors for novel treatments of schizophrenia.Re-exploring the N-phenylpicolinamide derivatives to develop mGlu4 ligands with improved affinity and in vitro microsomal stability.Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related DisordersPractical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate ReceptorsNovel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety.A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4.Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in MiceSynthesis and evaluation of N-(methylthiophenyl)picolinamide derivatives as PET radioligands for metabotropic glutamate receptor subtype 4.mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome.Lost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies.Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders
P2860
Q26773431-A2FDB992-3E6E-4C6F-9FAC-114FB1C06E45Q26782274-389CD861-EFF2-4EA6-BCB8-20A1D1601E74Q33604654-E90CD65E-3E19-4D05-9E13-5DFDB09CC68FQ35964194-1B5C9938-B6CC-44E2-8D6A-8D3C7FEA60AFQ36482311-8EFF84FC-FF6B-4A11-8AFA-6DDDD440D460Q37172873-743B0E8C-EC17-49A3-8627-06D28BBA07C8Q37183072-5A3287A0-B869-4E80-B94B-33DCD71A45D1Q38292149-17EAEF10-87FC-40E8-A4CF-8E1B294A78BEQ38630519-B18C58EB-8556-4607-BBC9-BEBD0AB7A1A8Q39085798-9A36A18D-19B9-4FC0-BA1C-3CCD667F9EFBQ39284158-F21B0861-E2D2-423B-B82E-A31D11997CD0Q41634132-299916C2-84FB-4495-BBE9-69EFE739C1C1Q42092185-1EDEB0D9-9B4C-4847-BE2B-8227296BC51EQ47738098-3EB57CB5-BD69-4D9D-872A-A1A42D8B62BBQ49591645-CDC47CD7-77CE-4D99-B5E8-371B9E3D7371Q58573091-678C8761-48AE-4B25-9A73-89CC32D8D3F3
P2860
Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of the novel ...... of neuropsychiatric disorders.
@ast
Characterization of the novel ...... of neuropsychiatric disorders.
@en
Characterization of the novel ...... of neuropsychiatric disorders.
@nl
type
label
Characterization of the novel ...... of neuropsychiatric disorders.
@ast
Characterization of the novel ...... of neuropsychiatric disorders.
@en
Characterization of the novel ...... of neuropsychiatric disorders.
@nl
prefLabel
Characterization of the novel ...... of neuropsychiatric disorders.
@ast
Characterization of the novel ...... of neuropsychiatric disorders.
@en
Characterization of the novel ...... of neuropsychiatric disorders.
@nl
P2093
P2860
P356
P1476
Characterization of the novel ...... of neuropsychiatric disorders.
@en
P2093
Brice Campo
Christelle Boléa
Emmanuel Le Poul
Françoise Girard
Ian J Reynolds
Isabelle Royer-Urios
Jacob Raber
Jason M Uslaner
Massimiliano Fonsi
Matthew J Davis
P2860
P304
P356
10.1124/JPET.114.214437
P407
P577
2014-06-19T00:00:00Z